« Previous
Next »
Fertility and Sterility
Volume 91, Issue 3
, Pages 930.e7-930.e11
, March 2009
The effect of treatment with growth hormone on fertility outcome in eugonadal women with growth hormone deficiency: report of four cases and review of the literature
References
- Growth hormone is required for ovarian follicular growth. Endocrinology. 2002;143:4104–4112
- . Role of growth hormone and prolactin in the control of reproduction: what are we learning from transgenic and knock-out animals?. Steroids. 1999;64:598–604
- . Impaired reproductive function in women treated for growth hormone deficiency during childhood. Clin Endocrinol (Oxf). 1997;46:681–689
- . Cotreatment with human growth hormone and gonadotropins for induction of ovulation: a controlled clinical trial. Fertil Steril. 1990;53:254–260
- . Synergistic effect of growth hormone and gonadotropins in achieving conception in “clonidine-negative” patients with unexplained infertility. Ann N Y Acad Sci. 1991;626:250–265
- . Growth hormone: roles in female reproduction. J Endocrinol. 2001;168:1–23
- . Growth hormone as an amplifier of insulin-like growth factor-I action: potentiated oestradiol accumulation. J Endocrinol. 1997;152:201–209
- . Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertil Steril. 1992;58:726–732
- In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab. 1993;77:61–67
- . Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a synergistic effect with human chorionic gonadotropin. Fertil Steril. 1992;57:92–96
- Effects of growth hormone, activin, and follistatin on the development of preantral follicle from immature female mice. Endocrinology. 1998;139:2342–2347
- . Localization of binding sites for IGF-I, insulin and GH in the sow ovary. J Endocrinol. 1999;163:363–372
- . Patterns of ovarian growth and development in cattle with a growth hormone receptor deficiency. J Anim Sci. 1998;76:212–219
- . Growth hormone (GH) substitution in hypogonadotropic, GH-deficient women decreases the follicle-stimulating hormone threshold for monofollicular growth. J Clin Endocrinol Metab. 1999;84:590–595
- . Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations. Hum Reprod. 1999;14:628–635
- . The promotory effect of growth hormone on the developmental competence of in vitro matured bovine oocytes is due to improved cytoplasmic maturation. Mol Reprod Dev. 1998;49:444–453
- . Ovarian follicle apoptosis in bovine growth hormone transgenic mice. Biol Reprod. 2000;62:103–107
- . Changes in and partial identification of the plasminogen activator and plasminogen activator inhibitor systems during ovarian follicular maturation in the pig. Biol Reprod. 1990;43:636–642
- . Uterus size and ovarian morphology in women with isolated growth hormone deficiency, hypogonadotrophic hypogonadism and hypopituitarism. Clin Endocrinol (Oxf). 2004;61:567–572
- . Clinical applications of growth hormone for ovarian stimulation. Hum Reprod Update. 1995;1:264–275
- . Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003;9:61–76
- . High risk pregnancies in hypopituitary women. Hum Reprod. 2002;17:1464–1467
- . Successful pregnancy and birth after sequential cotreatment with growth hormone and gonadotropins in a woman with panhypopituitarism: a new treatment protocol. Fertil Steril. 2000;74:1248–1250
- . Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev. 1985;6:400–420
- . Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil Steril. 1994;62:113–120
D.V. is an employee and stockholder of Eli Lilly & Co. A.G. has nothing to disclose. D.M. has nothing to disclose. A.B. has nothing to disclose. A.F. has nothing to disclose. V.C. has nothing to disclose. R.M. has nothing to disclose. A.P. has nothing to disclose. L.D. has nothing to disclose.
This work was supported by grants from the Endocrinologia 33 Onlus.
PII: S0015-0282(08)04056-9
doi: 10.1016/j.fertnstert.2008.09.065
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 91, Issue 3
, Pages 930.e7-930.e11
, March 2009

